Yu L - Search Results

1

Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients.

Zhu L, Yang P, Zhao Y, Zhuang Z, Wang Z, Song R, Zhang J, Liu C, Gao Q, Xu Q, Wei X, Sun HX, Ye B, Wu Y, Zhang N, Lei G, Yu L, Yan J, Diao G, Meng F, Bai C, Mao P, Yu Y, Wang M, Yuan Y, Deng Q, Li Z, Huang Y, Hu G, Liu Y, Wang X, Xu Z, Liu P, Bi Y, Shi Y, Zhang S, Chen Z, Wang J, Xu X, Wu G, Wang FS, Gao GF, Liu L, Liu WJ. Zhu L, et al. Among authors: yu l, yu y. Immunity. 2020 Sep 15;53(3):685-696.e3. doi: 10.1016/j.immuni.2020.07.009. Epub 2020 Jul 19. Immunity. 2020. PMID: 32783921 Free PMC article.

2

The Notch1/cyclooxygenase-2/Snail/E-cadherin pathway is associated with hypoxia-induced hepatocellular carcinoma cell invasion and migration.

Yu LX, Zhou L, Li M, Li ZW, Wang DS, Zhang SG. Yu LX, et al. Oncol Rep. 2013 Jan;29(1):362-70. doi: 10.3892/or.2012.2103. Epub 2012 Oct 23. Oncol Rep. 2013. PMID: 23124652

3

Somatic mutation profiling of liver and biliary cancer by targeted next generation sequencing.

Zhang BL, Ji X, Yu LX, Gao Y, Xiao CH, Liu J, Zhao DX, Le Y, Diao GH, Sun JY, Li GH, Lei GL, Yu P, Wang RL, Wu JZ, Yang PH, Yan J, Li JY, Xu JJ, Zhang SG, Tian H. Zhang BL, et al. Oncol Lett. 2018 Nov;16(5):6003-6012. doi: 10.3892/ol.2018.9371. Epub 2018 Aug 29. Oncol Lett. 2018. PMID: 30344748 Free PMC article.

4

Exosomal microRNAs as potential biomarkers for cancer cell migration and prognosis in hepatocellular carcinoma patient-derived cell models.

Yu LX, Zhang BL, Yang Y, Wang MC, Lei GL, Gao Y, Liu H, Xiao CH, Xu JJ, Qin H, Xu XY, Chen ZS, Zhang DD, Li FG, Zhang SG, Liu R. Yu LX, et al. Oncol Rep. 2019 Jan;41(1):257-269. doi: 10.3892/or.2018.6829. Epub 2018 Oct 29. Oncol Rep. 2019. PMID: 30542726 Free PMC article.

5

Increased circulating level of interleukin-6 and CD8⁺ T cell exhaustion are associated with progression of COVID-19.

Yang PH, Ding YB, Xu Z, Pu R, Li P, Yan J, Liu JL, Meng FP, Huang L, Shi L, Jiang TJ, Qin EQ, Zhao M, Zhang DW, Zhao P, Yu LX, Wang ZH, Hong ZX, Xiao ZH, Xi Q, Zhao DX, Yu P, Zhu CZ, Chen Z, Zhang SG, Ji JS, Wang FS, Cao GW. Yang PH, et al. Among authors: yu p, yu lx. Infect Dis Poverty. 2020 Nov 25;9(1):161. doi: 10.1186/s40249-020-00780-6. Infect Dis Poverty. 2020. PMID: 33239109 Free PMC article.

6

Long non-coding ribonucleic acid W5 inhibits progression and predicts favorable prognosis in hepatocellular carcinoma.

Lei GL, Fan HX, Wang C, Niu Y, Li TL, Yu LX, Hong ZX, Yan J, Wang XL, Zhang SG, Ren MJ, Yang PH. Lei GL, et al. World J Gastroenterol. 2021 Jan 7;27(1):55-68. doi: 10.3748/wjg.v27.i1.55. World J Gastroenterol. 2021. PMID: 33505150 Free PMC article.

7

Upregulation of long noncoding RNA W42 promotes tumor development by binding with DBN1 in hepatocellular carcinoma.

Lei GL, Niu Y, Cheng SJ, Li YY, Bai ZF, Yu LX, Hong ZX, Liu H, Liu HH, Yan J, Gao Y, Zhang SG, Chen Z, Li RS, Yang PH. Lei GL, et al. World J Gastroenterol. 2021 May 28;27(20):2586-2602. doi: 10.3748/wjg.v27.i20.2586. World J Gastroenterol. 2021. PMID: 34092977 Free PMC article.

8

Long noncoding RNA FAM66C promotes tumor progression and glycolysis in intrahepatic cholangiocarcinoma by regulating hsa-miR-23b-3p/KCND2 axis.

Lei GL, Li Z, Li YY, Hong ZX, Wang S, Bai ZF, Sun F, Yan J, Yu LX, Yang PH, Yang ZY. Lei GL, et al. Environ Toxicol. 2021 Nov;36(11):2322-2332. doi: 10.1002/tox.23346. Epub 2021 Aug 21. Environ Toxicol. 2021. PMID: 34418280

9

Construction and Validation of a Novel Nomogram Predicting Recurrence in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Post-Surgery Using an Innovative Liver Function-Nutrition-Inflammation-Immune (LFNII) Score: A Bicentric Investigation.

Zhang BL, Liu J, Diao G, Chang J, Xue J, Huang Z, Zhao H, Yu L, Cai J. Zhang BL, et al. Among authors: yu l. J Hepatocell Carcinoma. 2024 Mar 6;11:489-508. doi: 10.2147/JHC.S451357. eCollection 2024. J Hepatocell Carcinoma. 2024. PMID: 38463544 Free PMC article.

10

Cyclic adenosine monophosphate-responsive element-binding protein activation predicts an unfavorable prognosis in patients with hepatocellular carcinoma.

Yu L, Guo X, Zhang P, Qi R, Li Z, Zhang S. Yu L, et al. Onco Targets Ther. 2014 May 29;7:873-9. doi: 10.2147/OTT.S63594. eCollection 2014. Onco Targets Ther. 2014. PMID: 24926200 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24,434 results

Search Page